Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders, 74557-74560 [2023-23966]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices
Authority No. 523 of December 22,
2021.
Nicole L. Elkon,
Deputy Assistant Secretary for Professional
and Cultural Exchanges, Bureau of
Educational and Cultural Affairs, Department
of State.
[FR Doc. 2023–23983 Filed 10–30–23; 8:45 am]
BILLING CODE 4710–05–P
DEPARTMENT OF TRANSPORTATION
Federal Highway Administration
[Docket No. FHWA–2023–0044]
Agency Information Collection
Activities: Notice of Request for
Renewal of Currently Approved
Information Collection
Federal Highway
Administration (FHWA), DOT.
ACTION: Notice of request for renewal of
currently approved information
collection.
AGENCY:
The FHWA invites public
comments about our intention to request
the Office of Management and Budget’s
(OMB) approval for renewal of an
existing information collection that is
summarized below under
SUPPLEMENTARY INFORMATION. We are
required to publish this notice in the
Federal Register by the Paperwork
Reduction Act of 1995.
DATES: Please submit comments by
January 2, 2024.
ADDRESSES: You may submit comments
identified by DOT Docket Number
FHWA–2023–0044 by any of the
following methods:
• Website: https://
www.regulations.gov. Follow the
instructions for submitting comments
on the DOT electronic docket site.
• Fax: 1–202–493–2251.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue SE, Washington, DC
20590.
• Hand Delivery: U.S. Department of
Transportation, 1200 New Jersey
Avenue SE, Washington, DC 20590,
between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov at any time or to
U.S. Department of Transportation, 1200
New Jersey Avenue SE, Washington, DC
20590, between 9 a.m. and 5 p.m.
FOR FURTHER INFORMATION CONTACT: Mr.
Omar Elkassed, (213) 894–6718, Office
of Stewardship, Oversight, and Program
Management, Federal Highway
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:18 Oct 30, 2023
Jkt 262001
Administration, Department of
Transportation, 888 South Figueroa
Street, Suite 440, Los Angeles, CA
90017. Office hours are from 7 a.m. to
4 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
Title: Preparation and Execution of
the Project Agreement and
Modifications.
OMB Control Number: 2125–0529.
Background: Formal agreements
between State Transportation
Departments and the FHWA are
required for Federal-aid highway
projects. These agreements, referred to
as ‘‘project agreements’’ are written
contracts between the State and the
Federal government that define the
extent of work to be undertaken and
commitments made concerning a
highway project. Section 1305 of the
Transportation Equity Act for the 21st
Century (TEA–21, Pub. L. 105–178)
amended 23 U.S.C. 106(a) and
combined authorization of work and
execution of the project agreement for a
Federal-aid project into a single action.
States continue to have the flexibility to
use whatever format is suitable to
provide the statutory information
required, and burden estimates for this
information collection are not changed.
Respondents: There are 56
respondents, including 50 State
Transportation Departments, the District
of Columbia, the Commonwealth of
Puerto Rico, the Commonwealth of the
Northern Mariana Islands, Guam, the
Virgin Islands and American Samoa.
Depending on the size of and activity in
the above government agencies, the
number of project agreements executed
in any agency ranges between 10 and
1,500.
Frequency: On an on-going basis as
project agreements are written.
Estimated Average Annual Burden
per Response: There is a total of 23,809
agreements per year. Each agreement
requires 1 hour to complete.
Estimated Total Annual Burden
Hours: 23,809 hours.
Public Comments Invited: You are
asked to comment on any aspect of this
information collection, including: (1)
whether the proposed collection is
necessary for the FHWA’s performance;
(2) the accuracy of the estimated
burdens; (3) ways for the FHWA to
enhance the quality, usefulness, and
clarity of the collected information; and
(4) ways that the burden could be
minimized, including the use of
electronic technology, without reducing
the quality of the collected information.
The agency will summarize and/or
include your comments in the request
PO 00000
Frm 00157
Fmt 4703
Sfmt 4703
74557
for OMB’s clearance of this information
collection.
Authority: The Paperwork Reduction
Act of 1995; 44 U.S.C. chapter 35, as
amended; and 49 CFR 1.48.
Issued on: October 26, 2023.
Jazmyne Lewis,
Information Collection Officer.
[FR Doc. 2023–23997 Filed 10–30–23; 8:45 am]
BILLING CODE 4910–22–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2023–0038]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders
Federal Motor Carrier Safety
Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of applications for
exemption; request for comments.
AGENCY:
FMCSA announces receipt of
applications from 17 individuals for an
exemption from the prohibition in the
Federal Motor Carrier Safety
Regulations (FMCSRs) against persons
with a clinical diagnosis of epilepsy or
any other condition that is likely to
cause a loss of consciousness or any loss
of ability to control a commercial motor
vehicle (CMV) to drive in interstate
commerce. If granted, the exemptions
would enable these individuals who
have had one or more seizures and are
taking anti-seizure medication to
operate CMVs in interstate commerce.
DATES: Comments must be received on
or before November 30, 2023.
ADDRESSES: You may submit comments
identified by the Federal Docket
Management System Docket No.
FMCSA–2023–0038 using any of the
following methods:
• Federal eRulemaking Portal: Go to
www.regulations.gov/, insert the docket
number (FMCSA–2023–0038) in the
keyword box and click ‘‘Search.’’ Next,
choose the only notice listed, and click
on the ‘‘Comment’’ button. Follow the
online instructions for submitting
comments.
• Mail: Dockets Operations; U.S.
Department of Transportation, 1200
New Jersey Avenue SE, West Building
Ground Floor, Washington, DC 20590–
0001.
• Hand Delivery: West Building
Ground Floor, 1200 New Jersey Avenue
SE, Washington, DC, 20590–0001
between 9 a.m. and 5 p.m. ET Monday
through Friday, except Federal
Holidays.
SUMMARY:
E:\FR\FM\31OCN1.SGM
31OCN1
74558
Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices
• Fax: (202) 493–2251.
To avoid duplication, please use only
one of these four methods. See the
‘‘Public Participation’’ portion of the
SUPPLEMENTARY INFORMATION section for
instructions on submitting comments.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Chief, Medical
Programs Division, FMCSA, DOT, 1200
New Jersey Avenue SE, Washington, DC
20590–0001, (202) 366–4001,
fmcsamedical@dot.gov. Office hours are
8:30 a.m. to 5 p.m. ET Monday through
Friday, except Federal holidays. If you
have questions regarding viewing or
submitting material to the docket,
contact Dockets Operations, (202) 366–
9826.
SUPPLEMENTARY INFORMATION:
I. Public Participation
lotter on DSK11XQN23PROD with NOTICES1
A. Submitting Comments
If you submit a comment, please
include the docket number for this
notice (Docket No. FMCSA–2023–0038),
indicate the specific section of this
document to which each comment
applies, and provide a reason for each
suggestion or recommendation. You
may submit your comments and
material online or by fax, mail, or hand
delivery, but please use only one of
these means. FMCSA recommends that
you include your name and a mailing
address, an email address, or a phone
number in the body of your document
so that FMCSA can contact you if there
are questions regarding your
submission.
To submit your comment online, go to
https://www.regulations.gov/docket/
FMCSA-2023-0038. Next, choose the
only notice listed, click the ‘‘Comment’’
button, and type your comment into the
text box on the following screen. Choose
whether you are submitting your
comment as an individual or on behalf
of a third party and then submit.
If you submit your comments by mail
or hand delivery, submit them in an
unbound format, no larger than 81⁄2 by
11 inches, suitable for copying and
electronic filing. FMCSA will consider
all comments and material received
during the comment period.
B. Viewing Comments
To view comments go to
www.regulations.gov. Insert the docket
number (FMCSA–2023–0038) in the
keyword box and click ‘‘Search.’’ Next,
choose the only notice listed, and click
‘‘Browse Comments.’’ If you do not have
access to the internet, you may view the
docket online by visiting Dockets
Operations on the ground floor of the
DOT West Building, 1200 New Jersey
Avenue SE, Washington, DC 20590–
VerDate Sep<11>2014
17:18 Oct 30, 2023
Jkt 262001
0001, between 9 a.m. and 5 p.m. ET
Monday through Friday, except Federal
holidays. To be sure someone is there to
help you, please call (202) 366–9317 or
(202) 366–9826 before visiting Dockets
Operations.
C. Privacy Act
In accordance with 49 U.S.C.
31315(b)(6), DOT solicits comments
from the public on the exemption
request. DOT posts these comments,
without edit, including any personal
information the commenter provides, to
www.regulations.gov. As described in
the system of records notice DOT/ALL
14 (Federal Docket Management
System), which can be reviewed at
https://www.transportation.gov/
individuals/privacy/privacy-act-systemrecords-notices, the comments are
searchable by the name of the submitter.
II. Background
Under 49 U.S.C. 31136(e) and
31315(b), FMCSA may grant an
exemption from the FMCSRs for no
longer than a 5-year period if it finds
such exemption would likely achieve a
level of safety that is equivalent to, or
greater than, the level that would be
achieved absent such exemption. The
statutes also allow the Agency to renew
exemptions at the end of the 5-year
period. FMCSA grants medical
exemptions from the FMCSRs for a 2year period to align with the maximum
duration of a driver’s medical
certification.
The 17 individuals listed in this
notice have requested an exemption
from the epilepsy and seizure disorders
prohibition in 49 CFR 391.41(b)(8).
Accordingly, the Agency will evaluate
the qualifications of each applicant to
determine whether granting the
exemption will achieve the required
level of safety mandated by statute.
The physical qualification standard
for drivers regarding epilepsy found in
§ 391.41(b)(8) states that a person is
physically qualified to drive a CMV if
that person has no established medical
history or clinical diagnosis of epilepsy
or any other condition which is likely
to cause the loss of consciousness or any
loss of ability to control a CMV.
In addition to the regulations, FMCSA
has published advisory criteria 1 to
assist medical examiners (MEs) in
determining whether drivers with
certain medical conditions are qualified
1 These criteria may be found in APPENDIX A TO
PART 391—MEDICAL ADVISORY CRITERIA,
section H. Epilepsy: § 391.41(b)(8), paragraphs 3, 4,
and 5, which is available on the internet at https://
www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/
CFR-2015-title49-vol5-part391-appA.pdf.
PO 00000
Frm 00158
Fmt 4703
Sfmt 4703
to operate a CMV in interstate
commerce.
The criteria states that if an individual
has had a sudden episode of a nonepileptic seizure or loss of
consciousness of unknown cause that
did not require anti-seizure medication,
the decision whether that person’s
condition is likely to cause the loss of
consciousness or loss of ability to
control a CMV should be made on an
individual basis by the ME in
consultation with the treating physician.
Before certification is considered, it is
suggested that a 6-month waiting period
elapse from the time of the episode.
Following the waiting period, it is
suggested that the individual have a
complete neurological examination. If
the results of the examination are
negative and anti-seizure medication is
not required, then the driver may be
qualified.
In those individual cases where a
driver has had a seizure or an episode
of loss of consciousness that resulted
from a known medical condition (e.g.,
drug reaction, high temperature, acute
infectious disease, dehydration, or acute
metabolic disturbance), certification
should be deferred until the driver has
recovered fully from that condition, has
no existing residual complications, and
is not taking anti-seizure medication.
Drivers who have a history of
epilepsy/seizures, off anti-seizure
medication, and seizure-free for 10
years, may be qualified to operate a
CMV in interstate commerce. Interstate
drivers with a history of a single
unprovoked seizure may be qualified to
drive a CMV in interstate commerce if
seizure-free and off anti-seizure
medication for a 5-year period or more.
As a result of MEs misinterpreting
advisory criteria as regulation,
numerous drivers have been prohibited
from operating a CMV in interstate
commerce based on the fact that they
have had one or more seizures and are
taking anti-seizure medication, rather
than an individual analysis of their
circumstances by a qualified ME based
on the physical qualification standards
and medical best practices.
On January 15, 2013, FMCSA
announced in a notice of final
disposition titled, ‘‘Qualification of
Drivers; Exemption Applications;
Epilepsy and Seizure Disorders,’’ (78 FR
3069), its decision to grant requests from
22 individuals for exemptions from the
regulatory requirement that interstate
CMV drivers have ‘‘no established
medical history or clinical diagnosis of
epilepsy or any other condition which
is likely to cause loss of consciousness
or any loss of ability to control a CMV.’’
Since that time, the Agency has
E:\FR\FM\31OCN1.SGM
31OCN1
Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices
published additional notices granting
requests from individuals for
exemptions from the regulatory
requirement regarding epilepsy found in
§ 391.41(b)(8).
To be considered for an exemption
from the epilepsy and seizure disorders
prohibition in § 391.41(b)(8), applicants
must meet the criteria in the 2007
recommendations of the Agency’s
Medical Expert Panel (78 FR 3069).
III. Qualifications of Applicants
James Byrd
James Byrd is a 56-year-old class D
license holder in Tennessee. They have
a history of seizure disorder and have
been seizure free since 2013. They take
anti-seizure medication with the dosage
and frequency remaining the same since
2021. Their physician states that they
are supportive of James Byrd receiving
an exemption.
Francis Chiacchieri
lotter on DSK11XQN23PROD with NOTICES1
Francis Chiacchieri is a 66-year-old
class B commercial driver’s license
(CDL) holder in Massachusetts. They
have a history of oligodendroglioma and
have been seizure free since September
2001. They take anti-seizure medication
with the dosage and frequency
remaining the same since February
2002. Their physician states that they
are supportive of Francis Chiacchieri
receiving an exemption.
that they are supportive of Christine
Green-McClure receiving an exemption.
are supportive of Lisa Martin receiving
an exemption.
Nicholas Hayes
Pedro Martinez
Nicholas Hayes is a 32-year-old class
B CDL holder in Virginia. They have a
history of an isolated seizure and have
been seizure free since July 26, 2012.
They take anti-seizure medication with
the dosage and frequency remaining the
same since August 2012. Their
physician states that they are supportive
of Nicholas Hayes receiving an
exemption.
Pedro Martinez is a 36-year-old class
C license holder in Texas. They have a
history of epilepsy and have been
seizure free since 2012. They take antiseizure medication with the dosage and
frequency remaining the same since
October 2002. Their physician states
that they are supportive of Pedro
Martinez receiving an exemption.
Alex Hohman
Cecil Massey is a 33-year-old class R
license holder in Mississippi. They have
a history of epilepsy and have been
seizure free since May 2015. They take
anti-seizure medication with the dosage
and frequency remaining the same since
December 2009. Their physician states
that they are supportive of Cecil Massey
receiving an exemption.
Alex Hohman is a 22-year-old class C
license holder in Pennsylvania. They
have a history of epilepsy and have been
seizure free since August 2015. They
take anti-seizure medication with the
dosage and frequency remaining the
same since August 2015. Their
physician states that they are supportive
of Alex Hohman receiving an
exemption.
Michelle Hughes
Michelle Hughes is a 45-year-old class
C license holder in North Carolina. They
have a history of epilepsy and have been
seizure free since 2007. They take antiseizure medication with the dosage and
frequency remaining the same since
2017. Their physician states that they
are supportive of Michelle Hughes
receiving an exemption.
Lane Freeman
Michael Keys
Lane Freeman is a 26-year-old class E
license holder in Florida. They have a
history of generalized epilepsy and have
been seizure free since April 1, 2013.
They take anti-seizure medication with
the dosage and frequency remaining the
same since November 3, 2011. Their
physician states that they are supportive
of Lane Freeman receiving an
exemption.
Michael Keys is a 44-year-old class C
license holder in Pennsylvania. They
have a history of seizure disorder and
have been seizure free since July 13,
2010. They take anti-seizure medication
with the dosage and frequency
remaining the same since September
2010. Their physician states that they
are supportive of Michael Keys
receiving an exemption.
Jeffrey Gomall
Matthew Lee
Jeffrey Gomall is a 52-year-old class D
license holder in Minnesota. They have
a history of generalized epilepsy and
have been seizure free since 2002. They
take anti-seizure medication with the
dosage and frequency remaining the
same since 2008. Their physician states
that they are supportive of Jeffrey
Gomall receiving an exemption.
Matthew Lee is a 48-year-old class CM
license holder in Georgia. They have a
history of epilepsy and have been
seizure free since February 2003. They
take anti-seizure medication with the
dosage and frequency remaining the
same since 2003. Their physician states
that they are supportive of Matthew Lee
receiving an exemption.
Christine Green-McClure
Lisa Martin
Christine Green-McClure is a 50-yearold class D license holder in New York.
They have a history of seizure disorder
and have been seizure free since 2007.
They take anti-seizure medication with
the dosage and frequency remaining the
same since 2007. Their physician states
Lisa Martin is a 41-year-old class D
license holder in New York. They have
a history of epilepsy and have been
seizure free since 1994. They take antiseizure medication with the dosage and
frequency remaining the same since
2012. Their physician states that they
VerDate Sep<11>2014
17:18 Oct 30, 2023
Jkt 262001
74559
PO 00000
Frm 00159
Fmt 4703
Sfmt 4703
Cecil Massey
James Philips
James Phillips is a 29-year-old class B
CDL holder in North Carolina. They
have a history of focal epilepsy and
have been seizure free since 2012. They
take anti-seizure medication with the
dosage and frequency remaining the
same since 2012. Their physician states
that they are supportive of James
Phillips receiving an exemption.
Joshua Pike
Joshua Pike is a 33-year-old class C
license holder in Maine. They have a
history of nocturnal generalized
convulsions and have been seizure free
since May 2014. They take anti-seizure
medication with the dosage and
frequency remaining the same since
2016. Their physician states that they
are supportive of Joshua Pike receiving
an exemption.
Alex Ramerth
Alex Ramerth is a 41-year-old class D
license holder in Minnesota. They have
a history of generalized epilepsy and
have been seizure free since 2010. They
take anti-seizure medication with the
dosage and frequency remaining the
same since 2010. Their physician states
that they are supportive of Alex
Ramerth receiving an exemption.
Maciej Skrzyniarz
Maciej Skrzyniarz is a 36-year-old
class A license holder in Illinois. They
have a history of generalized epilepsy
and have been seizure free since 2014.
They take anti-seizure medication with
the dosage and frequency remaining the
same since 2014. Their physician states
that they are supportive of Maciej
Skrzyniarz receiving an exemption.
E:\FR\FM\31OCN1.SGM
31OCN1
74560
Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices
IV. Request for Comments
In accordance with 49 U.S.C. 31136(e)
and 31315(b), FMCSA requests public
comment from all interested persons on
the exemption petitions described in
this notice. We will consider all
comments received before the close of
business on the closing date indicated
under the DATES section of the notice.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2023–23966 Filed 10–30–23; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2014–0383; FMCSA–
2014–0385; FMCSA–2014–0387; FMCSA–
2018–0139; FMCSA–2019–0109; FMCSA–
2019–0110; FMCSA–2021–0015]
Qualification of Drivers; Exemption
Applications; Hearing
Federal Motor Carrier Safety
Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of renewal of
exemptions; request for comments.
AGENCY:
FMCSA announces its
decision to renew exemptions for 13
individuals from the hearing
requirement in the Federal Motor
Carrier Safety Regulations (FMCSRs) for
interstate commercial motor vehicle
(CMV) drivers. The exemptions enable
these hard of hearing and deaf
individuals to continue to operate CMVs
in interstate commerce.
DATES: The exemptions are applicable
on November 19, 2023. The exemptions
expire on November 19, 2025.
Comments must be received on or
before November 30, 2023.
ADDRESSES: You may submit comments
identified by the Federal Docket
Management System Docket No.
FMCSA–2014–0383, Docket No.
FMCSA–2014–0385, Docket No.
FMCSA–2014–0387, Docket No.
FMCSA–2018–013, Docket No. FMCSA–
2019–0109, Docket No. FMCSA–2019–
0110, or Docket No. FMCSA–2021–0015
using any of the following methods:
• Federal eRulemaking Portal: Go to
www.regulations.gov, insert the docket
number (FMCSA–2014–0383, FMCSA–
2014–0385, FMCSA–2014–0387,
FMCSA–2018–0139, FMCSA–2019–
0109, FMCSA–2019–0110, or FMCSA–
2021–0015) in the keyword box and
click ‘‘Search.’’ Next, sort the results by
‘‘Posted (Newer-Older),’’ choose the first
notice listed, and click on the
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:18 Oct 30, 2023
Jkt 262001
‘‘Comment’’ button. Follow the online
instructions for submitting comments.
• Mail: Dockets Operations; U.S.
Department of Transportation, 1200
New Jersey Avenue SE, West Building
Ground Floor, Washington, DC 20590–
0001.
• Hand Delivery: West Building
Ground Floor, 1200 New Jersey Avenue
SE, Washington, DC 20590–0001,
between 9 a.m. and 5 p.m. ET Monday
through Friday, except Federal
Holidays.
• Fax: (202) 493–2251.
To avoid duplication, please use only
one of these four methods. See the
‘‘Public Participation’’ portion of the
SUPPLEMENTARY INFORMATION section for
instructions on submitting comments.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Chief, Medical
Programs Division, FMCSA, DOT, 1200
New Jersey Avenue SE, Room W64–224,
Washington, DC 20590–0001, (202) 366–
4001, fmcsamedical@dot.gov. Office
hours are 8:30 a.m. to 5 p.m. ET Monday
through Friday, except Federal holidays.
If you have questions regarding viewing
or submitting material to the docket,
contact Dockets Operations, (202) 366–
9826.
SUPPLEMENTARY INFORMATION:
I. Public Participation
A. Submitting Comments
If you submit a comment, please
include the docket number for this
notice (Docket No. FMCSA–2014–0383,
Docket No. FMCSA–2014–0385, Docket
No. FMCSA–2014–0387, Docket No.
FMCSA–2018–0139, Docket No.
FMCSA–2019–0109, Docket No.
FMCSA–2019–0110, or Docket No.
FMCSA–2021–0015), indicate the
specific section of this document to
which each comment applies, and
provide a reason for each suggestion or
recommendation. You may submit your
comments and material online or by fax,
mail, or hand delivery, but please use
only one of these means. FMCSA
recommends that you include your
name and a mailing address, an email
address, or a phone number in the body
of your document so that FMCSA can
contact you if there are questions
regarding your submission.
To submit your comment online, go to
www.regulations.gov/, insert the docket
number (FMCSA–2014–0383, FMCSA–
2014–0385, FMCSA–2014–0387,
FMCSA–2018–0139, FMCSA–2019–
0109, FMCSA–2019–0110, or FMCSA–
2021–0015) in the keyword box and
click ‘‘Search.’’ Next, sort the results by
‘‘Posted (Newer-Older),’’ choose the first
notice listed, click the ‘‘Comment’’
button, and type your comment into the
PO 00000
Frm 00160
Fmt 4703
Sfmt 4703
text box on the following screen. Choose
whether you are submitting your
comment as an individual or on behalf
of a third party and then submit.
If you submit your comments by mail
or hand delivery, submit them in an
unbound format, no larger than 81⁄2 by
11 inches, suitable for copying and
electronic filing. FMCSA will consider
all comments and material received
during the comment period.
B. Viewing Comments
To view comments go to
www.regulations.gov. Insert the docket
number (FMCSA–2014–0383, FMCSA–
2014–0385, FMCSA–2014–0387,
FMCSA–2018–0139, FMCSA–2019–
0109, FMCSA–2019–0110, or FMCSA–
2021–0015) in the keyword box and
click ‘‘Search.’’ Next, sort the results by
‘‘Posted (Newer-Older),’’ choose the first
notice listed, and click ‘‘Browse
Comments.’’ If you do not have access
to the internet, you may view the docket
online by visiting Dockets Operations
on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE,
Washington, DC 20590–0001, between 9
a.m. and 5 p.m. ET Monday through
Friday, except Federal holidays. To be
sure someone is there to help you,
please call (202) 366–9317 or (202) 366–
9826 before visiting Dockets Operations.
C. Privacy Act
In accordance with 49 U.S.C.
31315(b)(6), DOT solicits comments
from the public on the exemption
requests. DOT posts these comments,
without edit, including any personal
information the commenter provides, to
www.regulations.gov. As described in
the system of records notice DOT/ALL
14 (Federal Docket Management
System), which can be reviewed at
https://www.transportation.gov/
individuals/privacy/privacy-act-systemrecords-notices, the comments are
searchable by the name of the submitter.
II. Background
Under 49 U.S.C. 31136(e) and
31315(b), FMCSA may grant an
exemption from the FMCSRs for no
longer than a 5-year period if it finds
such exemption would likely achieve a
level of safety that is equivalent to, or
greater than, the level that would be
achieved absent such exemption. The
statutes also allow the Agency to renew
exemptions at the end of the 5-year
period. FMCSA grants medical
exemptions from the FMCSRs for a 2year period to align with the maximum
duration of a driver’s medical
certification.
The physical qualification standard
for drivers regarding hearing found in
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 88, Number 209 (Tuesday, October 31, 2023)]
[Notices]
[Pages 74557-74560]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23966]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2023-0038]
Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of applications for exemption; request for comments.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces receipt of applications from 17 individuals
for an exemption from the prohibition in the Federal Motor Carrier
Safety Regulations (FMCSRs) against persons with a clinical diagnosis
of epilepsy or any other condition that is likely to cause a loss of
consciousness or any loss of ability to control a commercial motor
vehicle (CMV) to drive in interstate commerce. If granted, the
exemptions would enable these individuals who have had one or more
seizures and are taking anti-seizure medication to operate CMVs in
interstate commerce.
DATES: Comments must be received on or before November 30, 2023.
ADDRESSES: You may submit comments identified by the Federal Docket
Management System Docket No. FMCSA-2023-0038 using any of the following
methods:
Federal eRulemaking Portal: Go to www.regulations.gov/,
insert the docket number (FMCSA-2023-0038) in the keyword box and click
``Search.'' Next, choose the only notice listed, and click on the
``Comment'' button. Follow the online instructions for submitting
comments.
Mail: Dockets Operations; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Washington, DC 20590-0001.
Hand Delivery: West Building Ground Floor, 1200 New Jersey
Avenue SE, Washington, DC, 20590-0001 between 9 a.m. and 5 p.m. ET
Monday through Friday, except Federal Holidays.
[[Page 74558]]
Fax: (202) 493-2251.
To avoid duplication, please use only one of these four methods.
See the ``Public Participation'' portion of the SUPPLEMENTARY
INFORMATION section for instructions on submitting comments.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, FMCSA, DOT, 1200 New Jersey Avenue SE,
Washington, DC 20590-0001, (202) 366-4001, [email protected]. Office
hours are 8:30 a.m. to 5 p.m. ET Monday through Friday, except Federal
holidays. If you have questions regarding viewing or submitting
material to the docket, contact Dockets Operations, (202) 366-9826.
SUPPLEMENTARY INFORMATION:
I. Public Participation
A. Submitting Comments
If you submit a comment, please include the docket number for this
notice (Docket No. FMCSA-2023-0038), indicate the specific section of
this document to which each comment applies, and provide a reason for
each suggestion or recommendation. You may submit your comments and
material online or by fax, mail, or hand delivery, but please use only
one of these means. FMCSA recommends that you include your name and a
mailing address, an email address, or a phone number in the body of
your document so that FMCSA can contact you if there are questions
regarding your submission.
To submit your comment online, go to https://www.regulations.gov/docket/FMCSA-2023-0038. Next, choose the only notice listed, click the
``Comment'' button, and type your comment into the text box on the
following screen. Choose whether you are submitting your comment as an
individual or on behalf of a third party and then submit.
If you submit your comments by mail or hand delivery, submit them
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for
copying and electronic filing. FMCSA will consider all comments and
material received during the comment period.
B. Viewing Comments
To view comments go to www.regulations.gov. Insert the docket
number (FMCSA-2023-0038) in the keyword box and click ``Search.'' Next,
choose the only notice listed, and click ``Browse Comments.'' If you do
not have access to the internet, you may view the docket online by
visiting Dockets Operations on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE, Washington, DC 20590-0001, between
9 a.m. and 5 p.m. ET Monday through Friday, except Federal holidays. To
be sure someone is there to help you, please call (202) 366-9317 or
(202) 366-9826 before visiting Dockets Operations.
C. Privacy Act
In accordance with 49 U.S.C. 31315(b)(6), DOT solicits comments
from the public on the exemption request. DOT posts these comments,
without edit, including any personal information the commenter
provides, to www.regulations.gov. As described in the system of records
notice DOT/ALL 14 (Federal Docket Management System), which can be
reviewed at https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices, the comments are searchable by the name of
the submitter.
II. Background
Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption
from the FMCSRs for no longer than a 5-year period if it finds such
exemption would likely achieve a level of safety that is equivalent to,
or greater than, the level that would be achieved absent such
exemption. The statutes also allow the Agency to renew exemptions at
the end of the 5-year period. FMCSA grants medical exemptions from the
FMCSRs for a 2-year period to align with the maximum duration of a
driver's medical certification.
The 17 individuals listed in this notice have requested an
exemption from the epilepsy and seizure disorders prohibition in 49 CFR
391.41(b)(8). Accordingly, the Agency will evaluate the qualifications
of each applicant to determine whether granting the exemption will
achieve the required level of safety mandated by statute.
The physical qualification standard for drivers regarding epilepsy
found in Sec. 391.41(b)(8) states that a person is physically
qualified to drive a CMV if that person has no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause the loss of consciousness or any loss of ability to
control a CMV.
In addition to the regulations, FMCSA has published advisory
criteria \1\ to assist medical examiners (MEs) in determining whether
drivers with certain medical conditions are qualified to operate a CMV
in interstate commerce.
---------------------------------------------------------------------------
\1\ These criteria may be found in APPENDIX A TO PART 391--
MEDICAL ADVISORY CRITERIA, section H. Epilepsy: Sec. 391.41(b)(8),
paragraphs 3, 4, and 5, which is available on the internet at
https://www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf.
---------------------------------------------------------------------------
The criteria states that if an individual has had a sudden episode
of a non-epileptic seizure or loss of consciousness of unknown cause
that did not require anti-seizure medication, the decision whether that
person's condition is likely to cause the loss of consciousness or loss
of ability to control a CMV should be made on an individual basis by
the ME in consultation with the treating physician. Before
certification is considered, it is suggested that a 6-month waiting
period elapse from the time of the episode. Following the waiting
period, it is suggested that the individual have a complete
neurological examination. If the results of the examination are
negative and anti-seizure medication is not required, then the driver
may be qualified.
In those individual cases where a driver has had a seizure or an
episode of loss of consciousness that resulted from a known medical
condition (e.g., drug reaction, high temperature, acute infectious
disease, dehydration, or acute metabolic disturbance), certification
should be deferred until the driver has recovered fully from that
condition, has no existing residual complications, and is not taking
anti-seizure medication.
Drivers who have a history of epilepsy/seizures, off anti-seizure
medication, and seizure-free for 10 years, may be qualified to operate
a CMV in interstate commerce. Interstate drivers with a history of a
single unprovoked seizure may be qualified to drive a CMV in interstate
commerce if seizure-free and off anti-seizure medication for a 5-year
period or more.
As a result of MEs misinterpreting advisory criteria as regulation,
numerous drivers have been prohibited from operating a CMV in
interstate commerce based on the fact that they have had one or more
seizures and are taking anti-seizure medication, rather than an
individual analysis of their circumstances by a qualified ME based on
the physical qualification standards and medical best practices.
On January 15, 2013, FMCSA announced in a notice of final
disposition titled, ``Qualification of Drivers; Exemption Applications;
Epilepsy and Seizure Disorders,'' (78 FR 3069), its decision to grant
requests from 22 individuals for exemptions from the regulatory
requirement that interstate CMV drivers have ``no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause loss of consciousness or any loss of ability to
control a CMV.'' Since that time, the Agency has
[[Page 74559]]
published additional notices granting requests from individuals for
exemptions from the regulatory requirement regarding epilepsy found in
Sec. 391.41(b)(8).
To be considered for an exemption from the epilepsy and seizure
disorders prohibition in Sec. 391.41(b)(8), applicants must meet the
criteria in the 2007 recommendations of the Agency's Medical Expert
Panel (78 FR 3069).
III. Qualifications of Applicants
James Byrd
James Byrd is a 56-year-old class D license holder in Tennessee.
They have a history of seizure disorder and have been seizure free
since 2013. They take anti-seizure medication with the dosage and
frequency remaining the same since 2021. Their physician states that
they are supportive of James Byrd receiving an exemption.
Francis Chiacchieri
Francis Chiacchieri is a 66-year-old class B commercial driver's
license (CDL) holder in Massachusetts. They have a history of
oligodendroglioma and have been seizure free since September 2001. They
take anti-seizure medication with the dosage and frequency remaining
the same since February 2002. Their physician states that they are
supportive of Francis Chiacchieri receiving an exemption.
Lane Freeman
Lane Freeman is a 26-year-old class E license holder in Florida.
They have a history of generalized epilepsy and have been seizure free
since April 1, 2013. They take anti-seizure medication with the dosage
and frequency remaining the same since November 3, 2011. Their
physician states that they are supportive of Lane Freeman receiving an
exemption.
Jeffrey Gomall
Jeffrey Gomall is a 52-year-old class D license holder in
Minnesota. They have a history of generalized epilepsy and have been
seizure free since 2002. They take anti-seizure medication with the
dosage and frequency remaining the same since 2008. Their physician
states that they are supportive of Jeffrey Gomall receiving an
exemption.
Christine Green-McClure
Christine Green-McClure is a 50-year-old class D license holder in
New York. They have a history of seizure disorder and have been seizure
free since 2007. They take anti-seizure medication with the dosage and
frequency remaining the same since 2007. Their physician states that
they are supportive of Christine Green-McClure receiving an exemption.
Nicholas Hayes
Nicholas Hayes is a 32-year-old class B CDL holder in Virginia.
They have a history of an isolated seizure and have been seizure free
since July 26, 2012. They take anti-seizure medication with the dosage
and frequency remaining the same since August 2012. Their physician
states that they are supportive of Nicholas Hayes receiving an
exemption.
Alex Hohman
Alex Hohman is a 22-year-old class C license holder in
Pennsylvania. They have a history of epilepsy and have been seizure
free since August 2015. They take anti-seizure medication with the
dosage and frequency remaining the same since August 2015. Their
physician states that they are supportive of Alex Hohman receiving an
exemption.
Michelle Hughes
Michelle Hughes is a 45-year-old class C license holder in North
Carolina. They have a history of epilepsy and have been seizure free
since 2007. They take anti-seizure medication with the dosage and
frequency remaining the same since 2017. Their physician states that
they are supportive of Michelle Hughes receiving an exemption.
Michael Keys
Michael Keys is a 44-year-old class C license holder in
Pennsylvania. They have a history of seizure disorder and have been
seizure free since July 13, 2010. They take anti-seizure medication
with the dosage and frequency remaining the same since September 2010.
Their physician states that they are supportive of Michael Keys
receiving an exemption.
Matthew Lee
Matthew Lee is a 48-year-old class CM license holder in Georgia.
They have a history of epilepsy and have been seizure free since
February 2003. They take anti-seizure medication with the dosage and
frequency remaining the same since 2003. Their physician states that
they are supportive of Matthew Lee receiving an exemption.
Lisa Martin
Lisa Martin is a 41-year-old class D license holder in New York.
They have a history of epilepsy and have been seizure free since 1994.
They take anti-seizure medication with the dosage and frequency
remaining the same since 2012. Their physician states that they are
supportive of Lisa Martin receiving an exemption.
Pedro Martinez
Pedro Martinez is a 36-year-old class C license holder in Texas.
They have a history of epilepsy and have been seizure free since 2012.
They take anti-seizure medication with the dosage and frequency
remaining the same since October 2002. Their physician states that they
are supportive of Pedro Martinez receiving an exemption.
Cecil Massey
Cecil Massey is a 33-year-old class R license holder in
Mississippi. They have a history of epilepsy and have been seizure free
since May 2015. They take anti-seizure medication with the dosage and
frequency remaining the same since December 2009. Their physician
states that they are supportive of Cecil Massey receiving an exemption.
James Philips
James Phillips is a 29-year-old class B CDL holder in North
Carolina. They have a history of focal epilepsy and have been seizure
free since 2012. They take anti-seizure medication with the dosage and
frequency remaining the same since 2012. Their physician states that
they are supportive of James Phillips receiving an exemption.
Joshua Pike
Joshua Pike is a 33-year-old class C license holder in Maine. They
have a history of nocturnal generalized convulsions and have been
seizure free since May 2014. They take anti-seizure medication with the
dosage and frequency remaining the same since 2016. Their physician
states that they are supportive of Joshua Pike receiving an exemption.
Alex Ramerth
Alex Ramerth is a 41-year-old class D license holder in Minnesota.
They have a history of generalized epilepsy and have been seizure free
since 2010. They take anti-seizure medication with the dosage and
frequency remaining the same since 2010. Their physician states that
they are supportive of Alex Ramerth receiving an exemption.
Maciej Skrzyniarz
Maciej Skrzyniarz is a 36-year-old class A license holder in
Illinois. They have a history of generalized epilepsy and have been
seizure free since 2014. They take anti-seizure medication with the
dosage and frequency remaining the same since 2014. Their physician
states that they are supportive of Maciej Skrzyniarz receiving an
exemption.
[[Page 74560]]
IV. Request for Comments
In accordance with 49 U.S.C. 31136(e) and 31315(b), FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated under the DATES
section of the notice.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2023-23966 Filed 10-30-23; 8:45 am]
BILLING CODE 4910-EX-P
